FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced new data from its prospective ...
A new study can help guide proper treatment course for patients depending on heart function and severity of heart damage. Patients identified by nuclear stress testing as having severe stress-induced ...
Following a heart transplant, patients must undergo surgical biopsies so that clinicians can monitor for signs of organ rejection. A new study shows the promise of a biomarker that could allow doctors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results